Shanghai Argo Biopharmaceutical Co., Ltd.

This early-stage study tests whether a single injection of the experimental drug BW-20805-2 is safe and how it behaves in the body. It involves 24 healthy adults aged 18 to 60. The main goal is to check for side effects, not to treat any disease.

This early-phase study tests the safety of a new drug called BW-41012 in 40 healthy adults aged 18 to 65. Participants receive a single injection of the drug or a placebo. The main goal is to check for side effects and measure how the drug moves through the body. No treatment ben…

This early-phase study tests a single dose of BW-50218 in 24 healthy Chinese adults to see if it is safe and how the body processes it. Participants will be monitored for side effects and changes in blood tests, vital signs, and heart activity for up to a year. The goal is to gat…